Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H2A histone family member X (H2AX) is a variant of the H2A core histone involved in chromatin structure and function[1][3]. It plays a central role in the cellular response to DNA double-strand breaks (DSBs): upon DSB induction, H2AX is rapidly phosphorylated at serine 139 (γH2AX) by PI3 kinase family members such as ATM, ATR, or DNA-PK[1]. This phosphorylation event signals the presence of DNA damage, recruits repair proteins to the site of DNA lesions, and is vital for the maintenance of genomic stability[1][2][3]. The presence of γH2AX foci is widely used as a sensitive biomarker for monitoring DNA damage in cells[1][3]. H2AX contributes to nucleosome formation, chromatin remodeling, cell cycle arrest following DNA damage, and efficient DSB repair; its dysfunction is implicated in cancer and genome instability syndromes[1][3]. No direct therapeutic drugs are currently known to target H2AX, but its phosphorylated form is a key biomarker and research tool in assessing DNA damage and repair efficacy[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H2A histone family member X (H2AX).